Zobrazeno 1 - 10
of 328
pro vyhledávání: '"Ke Qh"'
Autor:
Wan DL; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Tong RL; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Tong XY; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Hu C; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Ke QH; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Yang X; Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Wu J; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. Electronic address: drwujian@zju.edu.cn.
Publikováno v:
Hepatobiliary & pancreatic diseases international : HBPD INT [Hepatobiliary Pancreat Dis Int] 2024 Oct; Vol. 23 (5), pp. 541-544. Date of Electronic Publication: 2023 Jun 02.
Autor:
Wan DL; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Hu C; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Ke QH; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Zhou T; Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Ruan L; Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Tang H; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Shen Y; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Publikováno v:
Journal of gastrointestinal oncology [J Gastrointest Oncol] 2024 Aug 31; Vol. 15 (4), pp. 1948-1956. Date of Electronic Publication: 2024 Jul 11.
Autor:
Xue L; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Wan DL; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Hu C; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Ke QH; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Zhou J; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Shen Y; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. Electronic address: shenyan@zju.edu.cn.
Publikováno v:
Hepatobiliary & pancreatic diseases international : HBPD INT [Hepatobiliary Pancreat Dis Int] 2024 Aug; Vol. 23 (4), pp. 434-437. Date of Electronic Publication: 2022 Jun 16.
Autor:
Zhou SQ; Department of Chemoradiotherapy, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China., Wan P; Department of Chemoradiotherapy, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China., Zhang S; Department of Chemoradiotherapy, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China., Ren Y; Department of Chemoradiotherapy, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China., Li HT; Department of Chemoradiotherapy, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China., Ke QH; Department of Chemoradiotherapy, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China. 3803354759@qq.com.
Publikováno v:
World journal of clinical oncology [World J Clin Oncol] 2024 Jul 24; Vol. 15 (7), pp. 859-866.
Autor:
Li LZ; Jingmen Central Hospital, Jingmen, China., Zhou C; AnKang University, School of Medicine, AnKang, China., Wang P; Jingmen Central Hospital, Jingmen, China., Ke QH; Jingmen Central Hospital, Jingmen, China., Zhang J; Jingmen Central Hospital, Jingmen, China., Lei SS; Department of Medicine, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, China., Li ZQ; Jingmen Central Hospital, Jingmen, China.
Publikováno v:
Medicine [Medicine (Baltimore)] 2023 Nov 03; Vol. 102 (44), pp. e34683.
Autor:
Miao XL; Hubei University of Science and Technology, Xianning, Hubei, China., Ma HM; Hubei University of Science and Technology, Xianning, Hubei, China., Ke QH; Hubei University of Science and Technology, Xianning, Hubei, China., Wang SY; Hubei University of Science and Technology, Xianning, Hubei, China., Zhou HF; Hubei University of Science and Technology, Xianning, Hubei, China., Zheng M; Hubei University of Science and Technology, Xianning, Hubei, China.
Publikováno v:
Phytochemical analysis : PCA [Phytochem Anal] 2022 Jun; Vol. 33 (4), pp. 577-589. Date of Electronic Publication: 2022 Feb 06.
Autor:
Ji, Zhongyin1,2,3 (AUTHOR), Ren, Xiaobin4 (AUTHOR), Jin, Jiayan1,2 (AUTHOR), Ye, Xin1,2 (AUTHOR), Yu, Hao4 (AUTHOR), Fang, Wenhan5 (AUTHOR), Li, Hui1,2 (AUTHOR), Zhao, Yihao1,2 (AUTHOR), Tao, Siyue1,2 (AUTHOR), Kong, Xiangxi1,2 (AUTHOR), Cheng, Jiao1,2 (AUTHOR), Shan, Zhi1,2 (AUTHOR), Chen, Jian1,2 (AUTHOR), Yao, Qingqing4 (AUTHOR) qingqingyao@wmu.edu.cn, Zhao, Fengdong1,2 (AUTHOR) zhaofengdong@zju.edu.cn, Liu, Junhui1,2 (AUTHOR) ljhzju@zju.edu.cn
Publikováno v:
Journal of Nanobiotechnology. 8/2/2024, Vol. 22 Issue 1, p1-20. 20p.
Autor:
Ke QH; Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China., Chen HY; Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China., He ZL; Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China., Lv Z; Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China., Xu XF; Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China., Qian YG; Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China., Zheng SS; Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Publikováno v:
Journal of cellular biochemistry [J Cell Biochem] 2019 Jan; Vol. 120 (1), pp. 253-263. Date of Electronic Publication: 2018 Sep 11.
Publikováno v:
Blood Cancer Journal
On the basis of the benefits of frontline radiation in early-stage, extranodal natural killer (NK)/T-cell lymphoma (ENKTL), we conducted the trial of concurrent chemoradiotherapy (CCRT) followed by three cycles of gemcitabine, dexamethasone and cispl
Autor:
Ke QH; Department of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou 310003, China., Huang HT; Department of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China., Ling Q; Department of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou 310003, China., Liu JM; Department of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada., Dong SY; China Liver Transplant Registry, Hangzhou 310003, China., He XX; China Liver Transplant Registry, Hangzhou 310003, China., Zhang WJ; Department of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou 310003, China., Zheng SS; Department of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou 310003, China. Electronic address: zyzss@zju.edu.cn.
Publikováno v:
Hepatobiliary & pancreatic diseases international : HBPD INT [Hepatobiliary Pancreat Dis Int] 2018 Aug; Vol. 17 (4), pp. 310-315. Date of Electronic Publication: 2018 Aug 03.